Among patients with moderate to severe atopic dermatitis, APG777 produced significant reductions in disease severity at 16 ...

Black patients with CSU have greater rates of angioedema, IgE levels, quality of life impairment, and BMI than White or Asian ...

Daily application of roflumilast cream for 52 weeks improves the signs and symptoms of AD in patients with various comorbid ...

Improvements in urticaria control and quality of life among patients with chronic inducible urticaria were observed with 20 ...

Umeclidinium-vilanterol is associated with improved clinical outcomes in symptomatic patients with chronic obstructive ...

In October, the U.S. Centers for Disease Control and Prevention changed its guidance, recommending COVID vaccines only for ...

A group of 15 states is suing the Trump administration over recent changes to federal vaccine guidelines for kids.

Among patients with PUPPP, 52.3% had atopy history, whereas 47.1% of matched control patients without PUPPP had atopy history ...

AAAAI President Carla Davis, MD, outlined 3 key initiatives involving AI, advocacy, and research at the 2026 AAAAI conference.

Tezepelumab is associated with beneficial changes in nasal polyp gene expression in patients with chronic rhinosinusitis with ...

Food oral immunotherapy can lead to sustained unresponsiveness or remission across a wide range of ages and diverse food ...

Twice-yearly depemokimab is effective and well-tolerated in Chinese patients with CRwNP, according to data from the ...